‘A growing body of evidence suggests that dietary strategies with the aim to reduce postprandial insulin response and increase fat oxidation, and that tend to restore metabolic flexibility, have a place in the prevention and treatment of obesity and associated metabolic disorders’. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.